Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Clinical trial NCT05776069 · RECRUITING
Trial details
- NCT number
- NCT05776069
- Sponsor
- Vega Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2029-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.